Contrasting Engineered Cell Lines vs. Cancer Cell Lines for Conventional ADC Cell-Based Potency Assay Development

  • Testing ADC potency through cytotoxicity assays, evaluating the tumour-killing activity of the payload following antibody internalisation
  • Ensuring assay robustness and specificity through the selection of a target antigen-expressing cell line